Pharmacological properties of a proenkephalin A-derived opioid peptide: BAM 18
- 1 June 1987
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 138 (3) , 359-366
- https://doi.org/10.1016/0014-2999(87)90474-2
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Minireview: Multiple MU opiate receptorsLife Sciences, 1986
- Interaction of Opiates with Opioid Binding Sites in the Bovine Adrenal Medulla: II. Interaction with K SitesJournal of Neurochemistry, 1985
- MU1: A very high affinity subtype of enkephalin binding sites in rat brainLife Sciences, 1985
- Morphiceptin: Biphasic inhibition of μ-opiate receptor ligandsPharmacology Biochemistry and Behavior, 1984
- K receptor activities of the three opioid peptide familiesLife Sciences, 1983
- Peptide E and other proenkephalin-derived peptides are potent kappa opiate receptor agonistsPeptides, 1983
- Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptorNature, 1982
- Endogenous opioid peptides: multiple agonists and receptorsNature, 1977
- The NH2-terminus of C-Fragment is resistant to the action of aminopeptidasesBiochemical and Biophysical Research Communications, 1977
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973